BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

GENETIC TECHNOLOGICAL INNOVATIONS, LLC — Receipts Report

LD-2 disclosure · 3rd Quarter - Amendment

GENETIC TECHNOLOGICAL INNOVATIONS, LLC

via PARK STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) · 2023Posted Jan 31, 2024Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: GENETIC TECHNOLOGICAL INNOVATIONS, LLC
Description: laboratory diagnostic testing services
Location: Arizona · United States of America

Registrant

Firm: PARK STRATEGIES, LLC
Description: Business consulting and government relations advocacy services.
Location: New York, New York, United States of America

Lobbying activities

1 issue

Trade (domestic/foreign)
Request for assistance from the U.S. Foreign and Commercial Service in facilitating an introduction to government healthcare officials in Sweden to discuss potential introduction of Blue Genes technology.
LobbyistsSEAN KING · CHRISTOPHER D'AMATO
Covered position (SEAN KING): Senior Policy Advisor for Asia, U.S. Foreign & Commercial Service
Covered position (CHRISTOPHER D'AMATO): Senior Counsel, U.S. Securities & Exchange Commission
TargetedIntl Trade Administration (ITA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.